usfda

 

Lupin to launch nearly 30 products in US market this fiscal

Jun 24 2018

Lupin sees opportunity to launch around 30 generic products in the world's largest pharmaceuticals market this year.

Biocon receives Establishment Inspection Report from USFDA

Jun 23 2018

Biocon said it has received EIR from the US health regulator on closure of inspection of its sterile drug product manufacturing facility in Bengaluru.

Cipla gets USFDA nod for generic Testosterone Cypionate injection

Jun 21 2018

Cipla said it has received final nod from the US health regulator for generic Testosterone Cypionate injection used for replacement therapy in males for deficiency.

Cipla gets USFDA nod for generic HIV drug

Jun 19 2018

Drug major Cipla today said it has received approval from the US health regulator to market Efavirenz tablets, used to treat HIV-1 infections in adults.

USFDA approves first product from Glenmark's US plant

Jun 19 2018

Glenmark Pharmaceuticals said the US health regulator has approved the first product from its Monroe, North Carolina based manufacturing facility.

Zydus Cadila gets USFDA nod for erectile dysfunction drug

Jun 19 2018

Drug firm Zydus Cadila today said it has received approval from the US health regulator to market Tadalafil tablets, used to erectile dysfunction, in the American market.

Strides Shasun gets USFDA nod for generic anti-fungal drug

Jun 19 2018

Drug firm Strides Shasun today said it has received approval from the US health regulator to market Ketoconazole tablets, used to treat fungal infections, in the American market.

Dr Reddy's gets temporary restraining order on sale of Suboxone

Jun 16 2018

Dr Reddy's Laboratories said that a US District Court has issued a temporary restraining order on the sale and commercialisation of its generic Buprenorphine and Naloxone sublingual film in US.

Dr Reddy's Lab shares surge 5% on USFDA nod for opioid drugs

Jun 15 2018

At NSE, shares of the company went up by 4.80 per cent to Rs 2,378.50.

Alembic Pharma shares up over 3 pc on USFDA nod

Jun 14 2018

Shares of Alembic Pharmaceuticals today rose by over 3 per cent after the company received approval from the US health regulator for its Doxycycline Hyclate capsules.

Indian Markets

 
  • SENSEX

    35,470.35 219.25   (-0.61 %)
  • NIFTY

    10,762.45 59.40   (-0.55 %)
sensex-box-shadowimg

Global Markets

 

Stocks In News

 

WHEELS INDIA

Mulls 1:1 Bonus Share Issue

CITY UNION BANK

To Issue 1:10 Bonus Shares; Record Date At July 11

AVANTI FEEDS

Approved Bonus Issue Of 1:2; Record Date At June 27

PHOENIX MILL

Arm Buys Under-Construction Asset For Rs 234 Cr In Indore At Auction

Brownfield Acquisition To Add Approx. 1.1 Mn Sq. Ft. To Co's Retail Portfolio

SYMPHONY

Co In Pact To Buy 95% Of Climate Tech Pty, Australia

Deal Size Stands At Rs 201-211 Cr In Valuation

TATA MOTORS

JLR Investor Presentation:

Have Exciting Products, Plans In The Pipeline To Generate Sustainable Growth

Aiming For A 4-7% EBIT Margin Over Medium Term, Will Invest 4.5 Bn GBP In FY19-21

Aiming For A 7-9% EBIT Margin Over Long Term

Long Term Investment Pegged At 12-13% Of Revenue

Retail Volume Grew By 1.7% & Revenue Grew By 6% In FY18

Also Launched Jaguar I-Pace As Co's First All Battery Electric Vehicle

ASIAN PAINTS

To Set Up 5 Lk KL/Annum Plant At Visakhapatnam For Rs 1,785 Cr

To Set Up 6 Lk KL/Annum Plant In Mysore For Rs 2,300 Cr

Co's International Business Did Not Perform Well In FY18

Economy & Inflated Currency Hit Co's Egyptian Operations

UNICHEM LAB

To Launch Generic Tadalafil After Filing ANDA With USFDA

BIOCON

Sterile Drug Product Manufacturing Facility In Bengaluru Receives EIR From USFDA

USFDA's Pre-Approval & Inspection Of Facility Done In April & May 2018

EIR Notifies That The Inspection Stands Closed

Co Committed To Global Standards Of Quality & Compliance

DR REDDY'S

Dr Reddy's Loses Patent Case With Eli Lilly Over Alimta

Co Cannot Launch Its Alternative Salt Forms Until The Eli Lilly Patent Expires

The U.S. District Court For The Southern District Of Indiana Ruled In Favour Of Lilly

The Eli Lilly Patent Expires In May 2022

twitter @BTVI